Related Experiment Video
Updated: Dec 12, 2025
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
CYP19A1 Gene Expression in Patients with Polycystic Ovarian Syndrome
Roselina Panghiyangani1, Purnomo Soeharso2, Andrijono3
1Department of Biomedic, Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, South Borneo.
Context:
Polycystic ovarian syndrome (PCOS) is a common endocrine system disorder among the women of reproductive age, yet the etiology of PCOS remains unclear. Infertility in females with PCOS can be caused by anovulation, high luteinizing hormone levels, and hyperandrogenism.
Aims:
This research analyzed the role of the aromatase gene (CYP19A1) in PCOS pathogenesis.
Settings And Design:
This study used an observational, cross-sectional design.
Subjects And Methods:
A total of 110 research participants (55 PCOS patients and 55 non-PCOS patients) were included in the study.
Statistical Analysis Used:
A real-time quantitative polymerase chain reaction was used to analyze the mRNA expression for aromatase in granulosa cells.
Results:
The relative expression of aromatase mRNA is lower in women with PCOS compared to those without PCOS (P < 0.05). Relative expression of CYP19A1 (aromatase) mRNA in PCOS group was 0.38 ± 0.25, whereas in non-PCOS group was 1.00 ± 0.00. The decline in aromatase activity contributes to an increase in testosterone level. This condition has a role in hyperandrogenism which is a typical characteristic of PCOS women. Granulosa cells in polycystic ovary undergo disturbance in the development and cannot respond to follicle-stimulating hormone (FSH) stimulation. Lack of stimulation of FSH causes induction inadequacy to aromatase enzyme activity in the aromatization process. The decline in FSH activity is caused by various factors that are associated with typical characteristics of PCOS.
Conclusions:
There is a decrease in the relative expression rate of granulosa cells' aromatase mRNA in women with PCOS compared to the non-PCOS.
Related Concept Videos
02:07Oogenesis
01:58Cell Specific Gene Expression
01:23Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...